Careers  |  Sign In  |  Register

Promising New Treatment Options for Migraine Disorder

Migraine disorder affects up to 36 million Americans each year but it is often neglected in the medical school curricula, The Los Angeles Times reports. Now, new treatment options offer promise for those suffering from migraines. In the field of drug development, researchers are targeting CGRP, a protein thought to be involved in pain regulation, and are “developing CGRP antibodies that can be injected beneath the skin.” In terms of supplements and herbs, “The American Academy of Neurology recommends several complementary treatments, including the herb butterbur (Petasites hybridus), as effective for reducing the severity and frequency of migraine headache in some patients.” Additionally, FDA approved transcranial magnetic stimulation has proven effective for pain management in patients experiencing migraines with aura.

Read it in the Los Angeles Times.